Use of a glycine B partial agonist for memory and learning enhancement or treatment of a cognitive disorder
US5087633A · kind A · utility
2Cited by
2References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 27, 1989 |
| Grant date | Feb 11, 1992 |
| Priority date | — |
| Expiry date | Jul 27, 2009 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/42
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A class of Glycine B partial agonists is described for use in memory and learning enhancement or for treatment of a cognitive disorder. Preferred Glycine B partial agonists include the compound D-cycloserine and its prodrug compounds.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.